Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
the placement looks positive, why?
$1 million it is not a huge amount of money. Therefore, it seems that they expect to become profitable relatively soon.
Cabroncita, could you ask about dilution
not about dilution in the past but rather whether they will be able to stop diluting the stock very soon.
Thanks in advance
Cal
The company is printing shares that is the problem why the stock price does not go up. Do you disagree ? How are they paying bills these days ?
I'm holding this stock and do not bash it.
then you effectively mean the company itself who is throwing out all these shares imo!
NEWS !!! Next attempt of an interview
RBID.Com Inc. CEO to Update Investment Community on MN1 Interview
NEWPORT BEACH, Calif., July 23, 2007 /PRNewswire-FirstCall via COMTEX/ --
RBID.Com, Inc. (RBID.PK) president and CEO Mr. Alan Rothman will be featured in a
Market News First interview on Monday, July 23, 2007, at 11:15 AM PDT. In the
interview, which can be heard via live internet streaming at http://www.mn1.com,
Mr. Rothman is expected to update shareholders
NEWS OUT - Calypte Reports Continued Positive Results of Aware(TM) HIV-1/2 Oral Fluid Rapid Test Evaluations at the 4th Annual AIDS Conference in Sydney, Australia
Monday July 23, 8:00 am ET
LAKE OSWEGO, Ore., July 23 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CBMC - News), medical diagnostic tests manufacturer for the rapid detection of antibodies to the human immunodeficiency virus (HIV) announced today the results, including positive cost and social implications, of a field evaluation of its Aware(TM) HIV-1/2 OMT (oral fluid) rapid test in Tanzania. The results of the evaluation are being presented this week in a poster at the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Sydney, Australia. Posters are scientific research publications presented in a display form for broad audience viewing, and have the advantage of providing an opportunity for extensive interaction between conference attendees and the poster authors.
The field evaluation was conducted on 1,055 clients at the African Medical & Research Foundation ("AMREF") ANGAZA Voluntary Counseling and Testing ("VCT") centers in Tanzania, a Non-Government Organization ("NGO"). ANGAZA is one of AMREF's primary projects in Tanzania; its objectives are to increase access to quality counseling for VCT centers as an entry to a continuum of HIV/AIDS care and prevention and to establish community care support for HIV positive clients. Of the clients tested at the ANGAZA center, 12%, or 123 clients, tested positive for HIV. The poster reported that the accuracy of the Aware(TM) HIV-1/2 OMT test was 100%, better than that of a comparable rapid blood test. (Calypte's rapid blood test was not evaluated in this study.). The poster also concluded that the evaluation "yielded a significant reduction in the cost of testing."
Roger Gale, Calypte's Chairman and Chief Executive Officer, stated, "We believe that oral fluid testing using our Aware(TM) HIV-1/2 OMT test will become the standard of care in many settings based on its continued strong clinical results coupled with the social and cost advantages of oral fluid testing. Our internal research has determined that the overall cost of oral fluid testing is less than that of blood testing. Oral fluid testing permits a healthcare worker to educate a group of clients simultaneously rather than requiring the individual attention demanded by all blood tests due to the administration, and blood handling and disposal requirements of blood-based tests. This is a significant advantage in resource-constrained settings requiring high client throughput. There are no other costs required to perform an oral fluid test and oral fluid has the obvious advantages of safety for both the client and healthcare worker and no hazardous disposal issues."
"We look forward to continuing to work with important NGOs like AMREF in Tanzania and elsewhere. We plan to support AMREF in their efforts to validate other aspects of HIV oral fluid rapid testing," Mr. Gale continued.
Mr. David Ocheng, a Medical Laboratory Technologist and project manager of AMREF who coordinated the field evaluation at ANGAZA elaborated, "We questioned the over 1,000 clients in this study on whether they would prefer a blood test or an oral fluid test, and, although they had consented to both for this to be a valid study, over 76.7% responded that they would prefer the oral procedure. We expect to now follow this question with a formal study on acceptance and welcome Calypte's support for this project. We believe acceptance of oral fluid testing has important implications, as our ability to increase the testing rate will have a direct correlation with our ability to then treat and care for HIV positive individuals. Ultimately, this is the best alternative screening method to support efforts to control the epidemic -- a very important goal of all of us involved in Tanzania."
Professor Willy Urassa of Muhimbili University College of Health Sciences in Tanzania ("MUCHS"), the lead investigator of this field study, commented, "Our study concluded that the test is indeed more cost effective than a blood test. This is one of the elements that would influence policy and decision makers in considering alternative rapid testing methods in the country. The results of sensitivity and specificity cannot be overemphasized, but when one considers overall cost, safety and acceptance, what will be left is to educate the public on the existence of alternative rapid testing methods through proper Government channels."
"We see that in many settings oral fluid testing can and should become the test of choice," Professor Urassa concluded.
Why do you think "no dilution" ?
NEWS out !
pls stop your useless pumping 50centt
HUSTLA, have you asked about ongoing dilution as well ? Would be a good test question in terms of the sincerity you mentioned.
Thanks for your effort
Cal
I guess they still print shares and dilute the stock ?!
final opportunity before numbers get announced ?
MKA, thanks for continued coverage of this stock in terms of technical analysis.
Most valuable input amongst those millions of messages posted every day.
I would also expect that we see trading sideways the next couple of days but not a drop to former levels around 0.0006.
Why ?
Some indicators cooled of a bit but are not too bad, additionally, with the first product operating (successfully) now, the fundamental situation is clearly different to the past. This stock has gained fundamental value by the successful roll-out.
The question mark to me is dilution ? Is there dilution ? Where is daily cash coming from ?
Keep going
Cal
NEWS: Calypte Reports Positive Results of Aware(TM) HIV-1/2 Oral Fluid Rapid Test
Evaluation at 3rd Annual South African AIDS Conference
LAKE OSWEGO, Ore., July 16, 2007 /PRNewswire-FirstCall via COMTEX/ -- Calypte
Biomedical Corporation (CBMC), medical diagnostic tests manufacturer for the
rapid detection of antibodies to the human immunodeficiency virus (HIV) announced
today the results and positive social implications of a field evaluation of its
Aware(TM) HIV-1/2 OMT (oral fluid) rapid test in the Republic of South Africa .
These results were recently presented in a poster at the 3rd South African AIDS
Conference in Durban last month. Posters are scientific research papers (in
poster presentation form) accepted by a conference for the education of its
attendees, typically displayed in a Poster Section on the conference floor.
The field evaluation was conducted on 600 clients of unknown HIV status at two
busy Voluntary Counseling and Testing ("VCT") clinics in South Africa. The
expected HIV prevalence rate was 30-40%; overall, 44% of the clients tested
positive. The poster reported that "the results obtained on OMT were comparable
with results on serum, and were statistically significant."
Study nurses responsible for the collection of samples described OMT (oral fluid
test) collection as "easy to do", and preferred the non-invasive oral fluid
collection method to the blood collection currently in use. Laboratory personnel
found the test procedure simple to perform and results easy to interpret. "This
assay may be a suitable alternative for VCT practices," was the poster's
conclusion.
Roger Gale, Calypte's Chairman and Chief Executive Officer, stated, "We have long
known the accuracy of the Aware(TM) HIV-1/2 oral fluid rapid test. The usage
studies that are now being reported are focusing on the social aspects of such a
test and we are pleased that there is strong sentiment for adopting oral fluid
testing. While changing long-established blood collection practice to the OMT
method is a process, we believe we are gaining momentum in making oral fluid an
acceptable alternative to blood testing. The recent approval of our oral fluid
test in India and the subsequent interest we are seeing from the government,
military and private sectors is very encouraging in this regard."
Johannes Viljoen, MBChB, FC Path (SA) Viro, at the College of Health Sciences of
the University of KwaZulu-Natal, Durban, South Africa and principal investigator
presenting this poster noted, "We specialize with individuals living in rural
settings of South Africa. In South Africa there are ongoing public health and
media campaigns to increase public awareness and uptake of HIV testing in an
attempt to curb the spread of the epidemic. We anticipate that offering a
non-invasive rapid test may quite possibly result in an enhanced uptake of
testing, mostly as a result of it being more acceptable and painless, even more
so for children. In our study, the technique was clearly preferred over
finger-sticks by the health care providers."
Dr. Pravi Moodley, Acting Head of the Department of Virology at the University of
KwaZulu-Natal and National Health Laboratory Service, Durban, South Africa and a
co-author of the poster commented, "The sampling of oral fluid for HIV antibody
rapid testing in resource constrained settings has advantages over the
conventional finger-prick blood which is currently used for HIV antibody rapid
testing. The obtaining of an oral fluid sample is much simpler since a community
health worker requiring minimal training will be able to obtain the sample. It is
also much safer since no sharps and sharps containers are necessary, obviating
the need for intensive health and safety training which may unnecessarily consume
financial and human resources in already resource constrained settings."
Further, our field evaluation of Calypte's Aware(TM) HIV-1/2 OMT Rapid Test
showed excellent correlation with blood samples," concluded Dr. Moodley.
investor 100,
imo they will get approval in China (rather sooner than later), then everything depends on whether they can successfully market the test(s) worldwide. It is probably fair to say that they have not completely proved it yet. The markets are difficult to assess but the big potential is definitely there.
Entering in the next couple of weeks could be a very good move (expect upcoming sFDA approval) for short and long term.
They can break even rather quickly if revenues start to come in and financing is not critical anymore for the next future but dilution could become an issue again when sales will take longer than expected.
Success in the US will probably require more time but is easier to predict.
Cal
To JK21: No I'm not
Good luck
Cal
Only tTechnical reaction, I agree
the momentum is not killed at all
Don't look on every trade right now folks it is waste of time
cosign, I'm waiting for approval in China as well, I don't have information about the time frame for it and haven't called TC for a while but this should be obviously more significant for the pps.
Of course, this is not about collecting approvals, they have to sell tests and make money by it in order to move the stock price.
Good luck
Cal
News: Calypte Announces India Approval
DCAI Regulatory Approval Received for the Aware(TM) HIV-1/2 Oral Fluid Rapid Test
LAKE OSWEGO, Ore., July 11, 2007 /PRNewswire-FirstCall via COMTEX/ -- Calypte
Biomedical Corporation (CBMC), medical diagnostic tests manufacturer for the
rapid detection of antibodies to the human immunodeficiency virus (HIV) announced
today that it has received registration and marketing approval for its Aware(TM)
HIV-1/2 OMT (oral fluid) rapid test in India from the Central Drugs Standard
Control Organisation, commonly referred to as the Drug Control Authority of India
("DCAI").
Roger Gale, Calypte's Chairman and Chief Executive Officer, stated, "As has been
highlighted in recent news reports, India is at the forefront in the fight
against HIV/AIDS and we have seen strong interest in our oral fluid tests from
both the Government and private sectors. A Calypte team has just returned from
India where we have begun putting in place the infrastructure to access and build
on this important business opportunity. We expect the market for HIV diagnostic
testing in India to grow significantly in the next few years."
Mr. Gale continued, "This DCAI approval is a significant milestone in the
advancement of our business; a very exciting time for all of us at the Company.
Once our non-invasive HIV diagnostic tests gain market acceptance, we anticipate
significant growth in market share of such tests. In addition to creating a
distribution network, we expect to establish both research and manufacturing
operations in India. While we will initially enter the Indian market with our
HIV-1/2 oral fluid rapid test, we are also considering introducing our Aware(TM)
HIV-1/2 rapid tests using both blood and urine samples to complement the current
oral fluid test. India is also a logical center for development of Calypte's new
products."
atot, did you buy PGNE ?
0.0013x0.0014
INXR will gap today
iFinix Corp. Signs Letter of Intent With Legend Securities to License the iFinix
RealTime Information Platform
JAMAICA, NY, Jul 10, 2007 (MARKET WIRE via COMTEX) -- iFinix Corp. (PINKSHEETS:
INXR) a provider of real-time financial information and services to active
traders and to the securities industry, announced today it has signed a letter of
intent with Legend Securities, Inc. ("Legend"), a New York City-based securities
broker/dealer, Member NASD/MSRB/SIPC, to license its iFinix RealTime Information
Platform.
iFinix RealTime is a desktop information platform that supplies streaming quotes
of the most timely and accurate pricing and volume data available for microcap
stocks today.
iFinix's Chairman, Drew Budhu, said, "Legend Securities, which is a full service
independent broker/dealer that provides trading and brokerage services to
institutional, active trading and retail clients, is the first of an expected
army of securities firms that will be offering their clients iFinix's quality
information on microcap stocks that is simply not available elsewhere."
Legend's CEO, Anthony Fusco, said, "We are eagerly anticipating introducing our
clients, who trade in microcap stocks, to the timely and accurate iFinix RealTime
Information Platform data. I am sure they will be happy with the excellent
functionality that this platform offers all microcap market participants."
Under the terms of the agreement iFinix will provide computer software for its
electronic securities information platform to Legend, which has agreed to
introduce iFinix's trading platform to its potential customers and existing
clients.
As Legend experiences increased trading volume, their clients (broker/dealers,
institutions, hedge funds, and active traders), will benefit as a result of using
the iFinix RealTime Information Platform in the form of lower price per ticket.
Upon completion of this letter of intent, both parties, iFinix and Legend, will
complete a non-disclosure and confidentiality agreement.
About Legend Securities, Inc.
Legend Securities, Inc. is a Full Service Securities Brokerage Firm, Member NASD,
MSRB, SIPC, providing services to individual as well institutional clients. The
company's products range from stocks, options, and fixed income instruments to
life insurance products. We specialize in providing a broad range of services to
the individual and institutional client. Legend's management is has over 50 years
of COMBINED experience in the Financial Services and Securities Industry.
Tsafi , are you expecting any FDA approvals end of this month, which could move some stocks ? Today or on Monday.
I guess FDA often sends approvals end of the month or the quarter. Do you have a specific FDA site for this or do you just follow the news ticker to track them ?
Cal
<<< I'm going to lite this fuse >>>
blackjack,
I had the feeling that you have been the one who sparked this minor run to 0.15, recently.
Just curious, am I correct?
Cal
hebroots,
could be a sign of dilution
How is the advertising campaign financed? Dilution ? Probably.
Cal
Is the company still diluting the stock or has it stopped now ?
Any recent comments by the company in this connection ? How are they financed?
I'm not bashing, I'm new to this stock, but there are a lot of shares out and it seems that a larger volume is required to significantly move this stock,
thanks
Cal
is this dilution going on ?
L2 6x7 now
INXR seems to break out this morning
Why don't you folks simply wait it out
or sell. The folks in charge obviously don't want to disclose anything at this point of time and you can't do anything about it. There won't be any selective disclosure for you (or us) which is even understandable (except for some selective toilet flushs).
If you want to avoid getting scammed just get out. Otherwise we have to take the risk and wait it out.
DFLY -> ETMO ?
What do you think ?
Thanks
Cal
Chart looks like a huge bungee jump
at least like the first part of a bungee jump,
interesting to watch if the rubber band is strong enough for a rebound (the usual second part of the bungee jump).
DFLY, nice call on TDXG, congrats
based on this call I hope you will pump NXNO soon again
from 1.5$ to 1.5 cents within 3 months
not bad huh what a diseaster haven't read such a dismal PR for a while
DALLAS, TX--(MARKET WIRE)--May 29, 2007 -- PrimeGen Energy Corporation (OTC BB:PGNE.OB - News) ("PrimeGen" or the "Company") today announced significant corporate developments.
Since PrimeGen's inception as an oil and gas startup company, management has been attempting to obtain independent financing in order to proceed with the orderly development of the projects in which the Company was successful in acquiring varying interests. Such projects include the Fayetteville, Arkansas project, the data analysis and development project in Kansas, and the revenue sharing project in the Manyberries area of Southern Alberta.
The Fayetteville and Kansas projects were acquired through the issuance of promissory notes to the vendors of the projects and it was the Company's intention to repay these amounts with revenues from resulting operations. The amounts due to the vendors are $2,500,000 (Fayetteville) and $675,000 (Kansas), plus interest at 6% from the date of the respective acquisitions. Significant additional capital is required to develop these projects.
The Manyberries project requires the Company to advance development funds in order to earn an interest in the resulting gas revenue earned by MB Gas Inc.
The Company was unable to independently fund its Fayetteville-related cash calls, including those related to the land integration process, with the result that the property vendor was obliged to provide the interim funding required in order to maintain the interest unimpaired.
The same was true for the Kansas project, and the vendor of that project agreed to temporarily provide minimal interim funding in order to keep the project operational.
To date the Company has been unable to advance any funds to the Manyberries project.
As at March 31, 2007, the Company had current liabilities of $3,839,613, inclusive of the Fayetteville and Kansas-related promissory notes.
Management has attempted to find partners or lenders willing to assist; however, due in part to the Company's recent trading performance, this task has proven impossible. Accordingly, it has been determined that a reorganization process must be initiated. As part of this process, PrimeGen intends to quitclaim and return the Fayetteville and Kansas assets to the respective vendors in consideration for the forgiveness and indemnification of and from all present and future liabilities related to the acquired assets. This process remains subject to the preparation and execution of required documentation.
In addition, it appears unlikely that PrimeGen will be capable of funding MB Gas and, accordingly, the Manyberries project is not expected to proceed.
At present and without any financing, the Company's ability to continue as a going concern remains in jeopardy. However, management is committed to reviewing all options available, including making all necessary changes and additions to the Board, with the aim of acquiring a viable business opportunity.
Mr. Glen Harder has resigned from the Board to pursue other opportunities. We wish him well and thank him for his work with the Company.
atot how about PGNE as bottom play
GEPT moves on news
ZYNX Announces Increased Orders in May
HNAB anyone ?
"Altomare said he wasn't disappointed at the sales pace, even though his company bought the items for $5 million and spent more than $2 million transporting them.
??? Because this gave him a perfect opportunity to throw out more shares at a higher price ?
The company's collection includes other Jackson items, such as master tapes of hundreds of songs, some never released, that will be sold later, he said."
I think he cannot sell such songs without permission by the person(s) having the copyrights for the songs or lyrics. The copyright is not connected to the actual possession and has to be negotiated separetely. imo.
Hope RA comments on this the next CC.
Anyone following the auction in progress ?
Any significant bids ?